Antibiotics are fundamental to modern medicine, essential for treating everything from routine skin infections to strep throat, and for protecting vulnerable patients receiving chemotherapy or being treated in intensive care units. But the proliferation of antibiotic-resistant bacteria—a result of decades of overuse in animal agriculture and human medicine combined with a lack of new drug development and innovation—has placed humanity on the precipice of what public health leaders call a “post-antibiotic” world in which even the most simple surgical procedure could have deadly consequences.
Although antibiotic resistance is not a new problem, its scope now constitutes a major threat to human health. According to the Centers for Disease Control and Prevention, at least 2 million Americans fall sick every year with antibiotic-resistant infections—and 23,000 die.
Medical and public health experts agree that addressing antibiotic resistance requires measures that will ensure both the prudent use of existing drugs and a robust pipeline of new drugs. Pew's antibiotic resistance project supports policies that would:
- Spur the creation of new antibiotics by removing the regulatory, economic, and scientific obstacles that impede antibiotic discovery and development.
- Establish stewardship programs to ensure that antibiotics are prescribed only when necessary in human health care settings.
- End the overuse of antibiotics in food animals.
On June 3, Representatives John Shimkus (R-IL) and Gene Green (D-TX) introduced the Antibiotic Development to Advance Patient Treatment (ADAPT) Act as a stand-alone bill in the U.S. House, adding to the bipartisan, bicameral momentum on Capitol Hill to establish a new regulatory pathway to approve much-needed antibiotics. Read More
The Pew Charitable Trusts sent a letter to Representatives John Shimkus (R-IL) and Gene Green (D-TX) strongly supporting the Antibiotic Development to Advance Patient Treatment (ADAPT) Act, introduced June 3. Read More
On June 3, Representatives John Shimkus (R-IL) and Gene Green (D-TX) introduced the Antibiotic Development to Advance Patient Treatment (ADAPT) Act as a stand-alone bill in the U.S. House. The legislation is designed to promote the development of much-needed antibiotics, and it mirrors similar ADAPT provisions that were included in the 21st Century Cures Act, a wide-ranging health care bill... Read More